Postoperative changes in thrombelastographic patterns were studied in thirty patients undergoing elective abdominal aortic bypass surgery. Native whole blood thrombelastography was performed preoperatively and on days 1, 2, and 3 postoperatively. The thrombelastographic changes included a decrease in r on day one (P<O.OOOI), with concurrent increases in et (P<O.OOOI) and MA (P < 0.001). On days 2 and 3 there were further increases in MA (P < 0.0001). These changes indicate enhanced procoagulant activity and progressive increases in maximum clot strength. The results confirm that hypercoagulability occurs in whole blood following abdominal aortic bypass surgery. Further studies are warranted to determine whether modification of postoperative hypercoagulability reduces the incidence of thrombotic complications in this group of patients.
Following abdominal aortic bypass surgery there are extensive changes in the plasma levels of several procoagulant factors!. These changes favour the development of hypercoagulability in the postoperative period. However, the clotting of whole blood is dependent not only on the plasma levels of coagulation proteins, but also on the function of blood platelets. As such, the measurement of coagulation proteins alone is not sufficient to determine whether hypercoagulability is present in whole blood. Moreover, routine coagulation tests such as prothrombin time, partial thromboplastin time, and thrombin clotting time are insensitive indicators of hypercoagulabiliti.
Patients undergoing abdominal aortic surgery have a high risk of perioperative myocardial infarction 2 • Although myocardial infarction can be caused by a number of factors, the pathogenesis often involves coronary artery thrombosis 3 • Hypercoagulability increases the likelihood of thrombosis'. If hypercoagulability is present following abdominal aortic surgery, it may contribute to the development of coronary artery thrombosis and other thrombotic complications. Therefore, it is important to determine the extent and time course of postoperative hypercoagulability in this group of patients. Only then will it be possible to decide whether clinical trials of antithrombotic therapy are warranted.
Thrombelastography differs from most traditional methods of assessing coagulation in that it provides a 'global' assessment of clot formation in whole blood s. Thrombelastography measures the viscoelastic changes that occur in blood as a result of fibrin formation and platelet aggregation s • The eventual thrombelastographic pattern is a functional assessment of the interaction between the various clotting factors and platelets. As such, thrombelastography may provide a useful method to examine the extent and time course of hypercoagulability in the postoperative period. The aim of the current study was to examine the postoperative changes in thrombelastographic patterns in patients undergoing abdominal aortic bypass surgery.
METHODS
The study was approved by the Human Rights Committee of the University of Western Australia. Written informed consent was obtained from all patients who participated. Inclusion criteria required patients to be undergoing elective abdominal aortic bypass surgery for infrarenal abdominal aortic aneurysm, or for aorto-occlusive disease. Preoperative exclusion criteria included a history of haematological, renal, or hepatic disease, or recent anticoagulant therapy. Patients receiving aspirin were not excluded. Postoperative exclusion criteria included perioperative blood loss in excess of 3.5 litres, a requirement for clotting factors or platelets, or postoperative bleeding requiring surgical re-exploration.
Anaesthesia
Patients received either general anaesthesia (GA) alone, or in GA combined with epidural analgesia (EA). The choice depended on patients' or anaesthetists' preference, and no attempt was made to randomize patients to either technique. In all cases anaesthetic premedication consisted of oral temazepam 10-20 mg one hour preoperatively. General anaesthesia was induced with thiopentone 4-5 mg.kg-I IV and either fentanyl 2 p,g.kg-I IV or morphine 0.1 mg.kg-I IV. Anaesthesia was maintained with 66070 nitrous oxide in oxygen, supplementary doses of fentanyl or morphine, and low concentrations of enflurane or isoflurane. Muscle relaxation was achieved with vecuronium. Intraoperative hypertension was controlled, if necessary, by intravenous glyceryl trinitrate 1 to 5 p,g.kg-I.min-I IV. Heparin 100 IU.kg-1 IV was given prior to placement of the aortic cross clamp. No other anticoagulant was given and no protamine was used. At the end of the procedure, residual neuromuscular blockade was reversed with neostigmine, and_ patients were extubated prior to being transferred to an intensive care unit. In patients receiving GA alone, postoperative analgesia was achieved with intravenous morphine 2 to 4 mg.hr-I .
Patients receiving EA had an epidural catheter inserted in a mid to low thoracic interspace before the induction of GA. Up to 10 ml of 0.5% bupivacaine plain was used to establish an epidural block with an upper dermatomallevel of T4-T6. Supplementary doses of bupivacaine 0.5% plain 3-5 ml were used intraoperatively. Intraoperative hypotension was avoided where possible by preoperative intravenous fluid loading. If hypotension occurred it was treated with boluses of metaraminol 0.5 mg IV. Postoperative analgesia was achieved with bupivacaine 0.1% plain 10 to 15 ml.hr-I by continuous infusion for 36 to 48 hours.
Blood Transfusion and Fluid Management
Maintenance fluid requirements and third space losses were replaced with an isotonic crystalloid solution (compound sodium lactate). Patients receiving EA had additional intravenous fluid loading with one litre of crystalloid solution. The first 500 ml of blood loss was replaced with 3.5% polygeline (HaemacceFM, Beringwerke, Marburg, Germany). Further blood loss was replaced with homologous packed red cells or autologous cell-saved blood. Postoperativelya combination of crystalloid and colloid solutions was used to maintain normal urine output and central venous Anaesthesia and Intensive Care, Vol. 22, No. 5, October, 1994 pressure. Further transfusions of homologous packed red cells were used to maintain haemoglobin levels above 10 g.dl-I .
Blood Tests
Venous blood samples were collected preoperatively on the day of surgery (day zero) and on days 1,2, and 3 postoperatively. Samples were collected using a double syringe technique, with the first syringe being discarded. Native whole blood thrombelastography was performed on each sample using disposable cups and pins (Haemoscope Corp., Morton Grove, IL, USA). The thrombelastograph (TEG) (Thrombelastograph D, Hellige, Freiburg, Germany) was pre-warmed for at least 30 minutes prior to each run and was calibrated daily using a calibration pin (Haemoscope Corp., Morton Grove, IL, USA). The same channel of the TEG was used for all samples. A stopwatch was used to ensure that the blood samples (0.36 ml) were placed in the TEG cups exactly four minutes after collection. A thin layer of paraffin was used to cover each sample. The r (reaction time), ex (angle), and MA (maximum amplitude) were recorded for each sample.
At the same time that the TEG samples were collected, further citrated blood samples were collected for measurement of plasma fibrinogen (FIB), factor VIII coagulant (VIIIC), and antithrombin III (AT-III). The measurement techniques were similar to those described in a previous study'. In addition, the platelet count (PC) was measured on each sample using a Coulter counter (Coulter STKS, Hialeah, FI, USA).
Statistical Analysis
The values for each parameter on days 1, 2, and 3 were compared with the values on day 0 using paired t tests. The values in patients receiving GA alone were compared to those receiving GA plus EA using unpaired t tests. A partial Bonferroni correction for mUltiple simultaneous comparisons was performed, and only P values < 0.01 were considered significant.
RESULTS
A total of 30 patients were studied. The mean age was 68.6 years (range 45-81 years) and the mean duration of surgery 3.5 hours (range 2.0-5.75 hours). The mean estimated blood loss in the first 24 hours was 1770 ml (range 700-3000 ml), and the mean homologous blood transfusion in the first 24 hours was 640 ml (range 0-1710 ml). Seventeen patients received GA alone, and 13 patients received GA plus EA. Five patients had received aspirin within seven days of surgery. Two of these were in the GA plus EA group. Blood samples were not collected in eight patients (4 receiving GA alone, and 4 receiving GA plus EA) on day 3 due to patient refusal.
The postoperative changes in coagulation variables are given in Table 1 . The TEG changes included a decrease in r on day one, with concurrent increases in 0: and MA. P values are given in Table 1 . On days 2 and 3 there were further increases in MA. Figure I depicts the actual changes in a typical patient. Fibrinogen and VIIIC levels increased on days 2 and 3. Antithrombin III levels decreased on day I and remained low on days 2 and 3. The platelet count also fell on day I and remained below control on days 2 and 3. Table 2 provides a breakdown of the values of patients undergoing GA alone vs those receiving GA plus EA. There were no significant differences between the two groups in relation to any of the variables measured (P>0.05 in all cases).
There were too few patients who had received aspirin to examine the effect of aspirin on TEG variables. However, the responses in patients who had received aspirin appeared to be similar to the responses in patients who had not received aspirin.
DISCUSSION
The postoperative changes in TEG patterns confirm that hypercoagulability occurs in whole blood following abdominal aortic bypass surgery. The decrease in r time indicates a more rapid onset of fibrin formation, and the increase in 0: indicates a faster rate of clot formation. l The increase in MA indicates increased maximum strength of clot'. Several factors contribute to clot strength, including platelet function, fibrinogen levels, and the activity of factors VIII and XIIP,6. At the same time there were significant increases in FIB and VIIIC, and decreases in AT-Ill. As such, the results provide substantial evidence of increased whole blood coagulability following abdominal aortic bypass surgery.
One of the problems with thrombelastography is the wide range of 'normal' values. The manufacturer's normal range for r is 9.5-14 minutes, for 0: is 29-43°, and for MA is 48-60 mm (native whole blood using plastic cups)'. However, these are somewhat arbitrary, because they include only one standard deviation (SD) about the mean. If two standard deviations were used (i.e. mean ± 2SD), the range for r would be 7-17 min, for 0: would be 22-50°, and for MA would be 42-66 mm'. Nevertheless, most laboratories use the manufacturer's 'normal' range S ,6. The wide range of normal values is due mostly to patient variability. However, minor variations in technique or calibration may explain systematic differences between different institutions. Therefore, in interpreting results, more consideration should be paid to the changes observed than to the absolute values. We observed substantial changes in r, iX, and MA. Moreover, the MA values on days 2 and 3 were above the upper limit of 'normal's. As such, our results provide quantitative as well as qualitative TEG evidence of hypercoagulability in the postoperative period. The postoperative increases in maximum clot strength occurred despite a reduction in platelet count. The reduction in platelet count was probably secondary to blood loss. Several previous studies have found that platelet aggregability per se does not change following major surgeryl,7. Platelets are often activated during surgery by circulating catecholamines and by contact with damaged endothelium. Intraoperative platelet activation may leave platelets relatively refractory to further stimulation due to their prior release of granule contents 7 • However, our results demonstrate that increased platelet-fibrin interaction occurred within 24 hours of surgery, and progressed over the following 48 hours. This suggests that platelet function is normal or increased following abdominal aortic bypass surgery.
Our results apply only to uncomplicated elective infrarenal abdominal aortic bypass procedures involving mild to moderate blood loss. Tuman et at have shown that moderate blood loss is rarely associated Anaesthesia and Intensive Care, Vol. 22, No. 5, October, 1994 with TEG evidence of hypocoagulability6. However, emergency or complicated procedures may be associated with massive blood loss, causing further dilution of clotting factors and platelets. In these situations patients may develop hypocoagulability in the initial postoperative period and not hypercoagulability. Similarly, procedures complicated by sepsis, tissue ischaemia, or organ failure may be associated with different coagulation responses.
Although there have been several studies on TEG changes during surgery, there have been few studies of TEG changes in the postoperative period. The TEG was used by Tuman et at to assess the coagulation status of patients undergoing both vascular and non-vascular surgery9. They found that the MA increased postoperatively in patients undergoing vascular surgery, but not in patients undergoing non-vascular surgery. This was not accompanied by a reduction in r time. However, they measured the TEG only on the first postoperative day and did not follow the changes on subsequent days. Moreover, their 'vascular' group included a large number of patients (> 50%) undergoing infra-inguinal vascular procedures. Abdominal aortic surgery differs from more peripheral vascular reconstruction in relation to the amount of tissue dissection and blood loss. As such, the findings of Tuman et at cannot be compared directly to this study.
Tuman et at examined also the effect of EA on postoperative coagulation status 9 . They found that the postoperative increase in MA was attentuated in patients receiving combined GA and EA compared to patients receiving GA alone. We did not find such a difference in patients undergoing abdominal aortic bypass surgery. This may be due to differences in the surgical procedure, because epidural anaesthesia ablates the responses to lower limb surgery more effectively than to upper abdominal surgeryiO. However, it is possible that our study failed to detect a difference due to the absence of randomization, and the small number of patients involved.
Several studies have shown that patients undergoing major vascular surgery have a high risk of perioperative myocardial infarction'. The majority occur within the first three days postoperatively'. It is possible that coronary artery thrombosis contributes to the development of myocardial infarction in the postoperative period'. The presence of hypercoagulability at this time may increase the likelihood of coronary artery thrombosis as well as other thrombotic complications. At present these considerations are only theoretical, because no studies have shown a direct relationship between coagulation status and outcome following major surgery. However, recent data suggest that the lower morbidity in patients receiving EA may be due, at least in part, to the effects of EA on coagulation' and fibrinolysis". Clearly, further studies are required to determine whether modification of postoperative hypercoagulability reduces the incidence of coronary artery thrombosis, and other thrombotic complications following major vascular surgery.
One of the difficulties in studying hypercoagulability has been the requirement to perform specific factor assays to document its presence". This has been timeconsuming and expensive, and often the results have not been available for several hours or days. As such, the TEG may be a useful alternative to identify postoperative hypercoagulability. The technique is simple and inexpensive, and the results can be obtained within one hour. Moreover, the TEG provides additional information about platelet function that cannot be obtained from individual factor assays. However, individual factor assays are still required to detect specific clotting defects and to determine the mechanism of coagulation changes.
In summary, the results of this study confirm that hypercoagulability occurs in whole blood following abdominal aortic bypass surgery. The TEG patterns demonstrate enhanced procoagulant activity and increased maximum strength of clot. The changes develop within 24 hours, but do not peak for several days. This period coincides with a period of high risk of thrombotic complications, including coronary artery thrombosis. Further studies are warranted to determine whether modification of postoperative hypercoagulability reduces the incidence of coronary artery thrombosis and other thrombotic complications in this group of patients.
